EADV: Ascletis/Sagimet’s Acne Drug Shows Rapid Efficacy In China Phase III Trial

 
• By Dexter Jie Yan
  
Denifanstat could offer a new therapy for moderate-to-severe acne vulgaris in China. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D